RT Journal
A1 Kuehn BM
T1 ANtipsychotic risks
JF JAMA
JO JAMA
YR 2009
FD February 25
VO 301
IS 8
SP 817
OP 817
DO 10.1001/jama.2009.199
UL http://dx.doi.org/10.1001/jama.2009.199
AB 
To assess the relative risks of atypical and typical antipsychotic drugs, scientists conducted a retrospective cohort study of Medicaid users in Tennessee (Ray WA et al. N Engl J Med. 2009;360[3]:225-235). The study included more than 44 000 users of typical antipsychotics, more than 46 000 users of atypical antipsychotics, and 186 000 matched controls.